Invesco Ltd. 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-05-20 3:19 pm Sale |
2021-05-18 | 13D | Evofem Biosciences, Inc. EVFM |
Invesco Ltd. IVZ |
316 13.000% |
-4,324![]() (-93.19%) |
Filing |
2021-04-27 3:31 pm Sale |
2021-04-22 | 13D | Evofem Biosciences, Inc. EVFM |
Invesco Ltd. IVZ |
4,639 8.400% |
-614![]() (-11.68%) |
Filing |
2021-03-30 6:53 pm Sale |
2021-03-25 | 13D | Evofem Biosciences, Inc. EVFM |
Invesco Ltd. IVZ |
5,253 9.900% |
-1,801![]() (-25.53%) |
Filing |
2020-06-09 06:58 am Purchase |
2020-06-05 | 13D | Evofem Biosciences, Inc. EVFM |
Invesco Ltd. IVZ |
7,054 16.800% |
754![]() (+11.97%) |
Filing |